1. Савенкова НД. Нефрогенная артериальная гипертензия у детей и подростков: причины, классификация, диагностика. Рос вестн перинатол и педиатр 2017; 62(4):43-48 https://doi.org/10.21508/1027-4065-2017-62-4-43-48
2. Stein D, McNamara E. Congenital Anomalies of the Kidneys and Urinary Tract. Clin Perinatol 2022;49(3):791-798. https://doi.org/10.1016/j.clp.2022.06.002
3. Kutyrlo IE, Savenkova ND, Leviashvili ZG. Renal Prognosis of Vesicoureteral Refl ux with Congenital Anomalies of the Kidney and Urinary Tract in Children Pediatrics. Eastern Europe 2023;11:(2):187-193. https://doi.org/10.34883/PI.2023.11.2.003
4. Danziger P, Berman DR, Luckritz K. Severe congenital anomalies of the kidney and urinary tract: epidemiology can inform ethical decisionmaking. J Perinatology 2016;36:954-959. https://doi.org/10.1038/jp.2016.107
5. Dong S, Wang C, Li X. Noncoding rare variants of TBX6 in congenital anomalies of the kidney and urinary tract. Molecular Genetics and Genomics 2019;294(2):493-500. https://doi.org/10.1007/s00438-018-1522-6
6. Goodier P, Gupta IR, Westland R, Yosypiv I. Congenital Anomalies of the Kidneys. Pediatric Nephrology, 8th Edition. R. Shroff . Springer. 2022:79-114. https://doi.org/10.1007/978-3-030-52719-8
7. Кутырло ИЭ, Савенкова НД. Cakut-синдром у детей. Нефрология (Санкт-Петербург) 2017;21(3):18-24. https://doi.org/doi.org/10.24884/1561-6274-2017-3-18-24
8. Hideshi M, Yutaro H, Takahiko M. Guidelines for the Medical Management of Pediatric Vesicoureteral Reflux. J Urol 2020. https://doi.org/10.1111/iju.14223
9. Winnicki Е, Copp Р. Adolescents with Chronic Kidney Disease. From Diagnosis to End-Stage Disease. Springer Nature Switzerland AG https://doi.org/2019:81-84.doi.org/10.1007/978-3-319-97220-6
10. Simeoni M, Armeni A, Summaria C, Cerantonio A, Fuiano G. Current evidence on the use of anti-RAAS agents in congenital or acquired solitary kidney. Ren Fail 2017;39:660-670. https://doi.org/10.1080/0886022X.2017.1361840
11. Waraby BA, Abraham AG, Schwartz GJ, Wong CS, Muñoz A, Betoko A et al. Predictors of rapid progression of glomerular and nonglomerular kidney disease in children and adolescents: the chronic kidney disease in children (CKiD) cohort. Am J Kidney Dis 2015;65:878-888. https://doi.org/10.1053/j.ajkd.2015.01.008
12. The ESCAPE Trial Group. Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009; 361:1639-50. https://doi.org/10.1056/NEJMoa0902066
13. Vidi SR. Role of hypertension in progression of chronic kidney disease in children. Curr Opin Pediatr 2018;30:247-251. https://doi.org/0.1097/MOP.0000000000000595
14. Лысова ЕВ, Савенкова НД. CAKUT-синдром в этиологической структуре хронической болезни почек у детей и подростков. Нефрология 2017;21(3):69-74. https://doi.org/10.24884/1561-6274-2017-3-69-74
15. Кутырло ИЕ, Левиашвили ЖГ, Батраков ДД, Савенкова НД. Диспансерное наблюдение детей и подростков с врожденными аномалиями почек и мочевыводящих путей, ассоциированными с редкими наследственными синдромами. Росс вестн перинатол и пед 2022;67(6):68-74. https://doi.org/10.21508/1027-4065-2022-67-6-68-74
16. Belangero VMS, Prates LC, Watanabe A, Schvartsman BSG, Nussenzveig P, Cruz NA et al. Prospective cohort analyzing risk factors for chronic kidney disease progression in children. J Pediatr 2017;94:525-531. https://doi.org/10.1016/j.jped.2017.07.015
17. Walawender L, Becknell B, Matsell DG. Congenital anomalies of the kidney and urinary tract: defining risk factors of disease progression and determinants of outcomes. Pediatr Nephrol 2023 Mar 3. https://doi.org/10.1007/s00467-023-05899-w
18. Flynn JT, Mitsnefes M, Pierce C, Cole SR, Parekh RS, Furth SL et al. Blood pressure in children with chronic kidney disease: a report from the chronic kidney disease in children study. Hypertension 2008;52:631-637. https://doi.org/10.1161/HYPERTENSIONAHA.108.110635
19. VanDeVoorde RG, Mitsnefes MM. Hypertension and CKD. Adv Chronic Kidney Dis 2011;18:355-361. https://doi.org/10.1053/j.ackd.2011.03.003
20. Hadtstein C, Schaefer F. Hypertension in children with chronic kidney disease: pathophysiology and management. Pediatr Nephrol 2008;23:363-371. https://doi.org/10.1007/s00467-007-0643-7
21. Wuhl E, Mehls O, Schaefer F, ESCAPE Trial Group. Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int 2004;66:768-776. https://doi.org/10.1111/j.1523-1755.2004.00802.x
22. Murugapoopathy V, Gupta IR. A Primer on Congenital Anomalies of the Kidneys and Urinary Tracts (CAKUT). Clin J Am Soc Nephrol 2020;15(5):723-731. https://doi.org/10.2215/CJN.12581019
23. Mennuni S, Rubattu S, Pierelli G, Tocci G, Fofi C, Volpe M. Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage. J Hum Hypertens (2014) 28:74-79. https://doi.org/10.1038/jhh.2013.55
24. Judd E, Calhoun DA. Management of hypertension in CKD: beyond the guidelines. Adv Chronic Kidney Dis 2015;22:116-122. https://doi.org/10.1053/j.ackd.2014.12.001
25. Wheeler D, Becker GJ. Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease? Kidney Int 2013;83:377-383. https://doi.org/10.1038/ki.2012.425
26. Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 2017;140:3. https://doi.org/10.1542/peds.2017-1904
27. Dionne JM. Evidence-based guidelines for the management of hypertension in children with chronic kidney disease. Pediatr Nephrol 2015;30:1919-1927. https://doi.org/10.1007/s00467-015-3077-7
28. Samuels J, Ng D, Flynn JT, Mitsnefes M, Poffenbarger T, Warady BA et al. Ambulatory blood pressure patterns in children with chronic kidney disease. Hypertension 2012;60:43-50. https://doi.org/10.1161/HYPERTENSIONAHA.111.189266
29. Halbach S, Flynn J. Treatment of hypertension in children with chronic kidney disease. Curr Hypertens Rep 2015;17:503. https://doi.org/10.1007/s11906-014-0503-3
30. Stotter BR, Ferguson MA. Should ACE inhibitors and ARBs be used in combination in children? Pediatr Nephrol 2018; 2018:4046. https://doi.org/10.1007/s00467-018-4046-8
31. Watt KM, Avant D, Sherwin J, Benjamin DK, Hornik C, Benjamin DK Jr et al. Effect of renal function on antihypertensive drug safety and efficacy in children. Pediatr Nephrol 2018;33:139-146. https://doi.org/10.1007/s00467-017-3763-8
32. Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, et al. 2016 European society of hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 2016;34:1887-1920. https://doi.org/10.1097/HJH.0000000000001039
33. Gallibois CM, Jawa NA, Noone DG. Hypertension in pediatric patients with chronic kidney disease: management challenges. Int J Nephrol Renov Dis 2017;10:205-213
34. Flynn JT, Daniels SR, Hayman LL, Maahs DM, McCrindle BW, Mitsnefes M et al. Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American heart association. Hypertension 2014; 63:1116- 1135. https://doi.org/10.1161/HYP.0000000000000007
35. Gabriele MM, PC Koch Nogueira, Management of Hypertension in CAKUT: Protective Factor for CKD. Front Pediatr 2019 June 7. https://doi.org/doi.org/10.3389/fped.2019.00222. eCollection 2019
36. Каримджанов ИА, Исканова ГХ, Исраилова НА. Диагностика, мониторинг и лечение артериальной гипертензии у детей. Нефрология (Санкт-Петербург) 2023;27(1):31-40. https://doi.org/10.36485/1561-6274-2023-27-1-31-40
37. Robinson CH, Chanchlani R. High Blood Pressure in Children and Adolescents: Current Perspectives and Strategies to Improve Future Kidney and Cardiovascular Health. Kidney Int Rep 2022 Mar 1;7(5):954-970. https://doi.org/10.1016/j.ekir.2022.02.018
38. Ku E, McCulloch CE, Warady BA, Furth SL, Grimes BA, Mitsnefes MM. Twenty-four-hour ambulatory blood pressure versus clinic blood pressure measurements and risk of adverse outcomes in children with CKD. Clin J Am Soc Nephrol 2018; 13:422-428. https://doi.org/10.2215/CJN.09630917
39. Каримджанов ИА, Исканова ГХ, Исраилова НА. Хроническая болезнь почек у детей: проблемы артериальной гипертензии. Нефрология (Санкт-Петербург) 2019;23(5):47- 55. https://doi.org/10.24884/1561-6274-2019-23-5-47-55
40. Mistry K. Chronic kidney disease. Clinical Pediatric Nephrology. Third Edition. CRC Press Taylor & Francis Group 2017:601-627
41. Yo Han Ahn, Hee Gyung Kang, Il-Soo Ha. Risk Factors for the Progression of Chronic Kidney Disease in Children. Child Kidney Dis 2021;25:1-7. https://doi.org/10.3339/jkspn.2021.25.1.1
42. Kamath N, Iyengar A, George N and Luyckx VA, Department. Risk Factors and Rate of Progression of CKD in Children. Kidney Int Rep 2019; 4:1472-1477. https://doi.org/doi.org/10.1016/j.ekir.2019.06
43. Brunström M, Carlberg B. Benefits and harms of lower blood pressure treatment targets: systematic review and metaanalysis of randomised placebocontrolled trials. BMJ Open 2019;9:e026686. https://doi.org/10.1136/